Oragenics (OGEN) EBT Margin (2010 - 2023)
Oragenics' (OGEN) quarterly EBT Margin came in at 26960.69% in Q3 2023, down 2246302.0% YoY from N/an in Q3 2022, and down 16.33% on a QoQ basis from 23175.46% in Q2 2023.
Oragenics (OGEN) EBT Margin (2010 - 2023) Analysis & Trends
Oragenics (OGEN) has 7 years of EBT Margin data on file, last reported at 26960.69% in Q3 2023.
- Quarterly EBT Margin fell 2246302.0% year-over-year to 26960.69% in Q3 2023, while the trailing twelve-month figure through Dec 2023 was 54858.14% (down 4399418.0% YoY) and the FY2023 annual result came in at 54858.14%, down 4399418.0% from the prior year.
- EBT Margin declined to 26960.69% in Q3 2023, from 23175.46% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 4497.67% in Q3 2022 to a low of 30438.2% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -26,960.69% |
| Jun 30, 2023 | -23,175.46% |
| Mar 31, 2023 | -16,710.74% |
| Sep 30, 2022 | -4,497.67% |
| Jun 30, 2022 | -11,811.20% |
| Mar 31, 2022 | -30,438.20% |
| Dec 31, 2014 | -554.90% |
| Sep 30, 2014 | -512.19% |
| Jun 30, 2014 | -624.04% |
| Mar 31, 2014 | -764.41% |
| Dec 31, 2013 | -708.24% |
| Sep 30, 2013 | -3,680.50% |
| Jun 30, 2013 | -1,236.99% |
| Mar 31, 2013 | -901.30% |
| Dec 31, 2012 | -461.89% |
| Sep 30, 2012 | -967.25% |
| Jun 30, 2012 | -2,702.26% |
| Mar 31, 2012 | -424.91% |
| Dec 31, 2011 | -489.00% |
| Sep 30, 2011 | -515.85% |